When.com Web Search

  1. Ads

    related to: pharmacogenetic testing examples

Search results

  1. Results From The WOW.Com Content Network
  2. Pharmacogenomics - Wikipedia

    en.wikipedia.org/wiki/Pharmacogenomics

    Examples include KRAS test with cetuximab and EGFR test with gefitinib. Beside efficacy, germline pharmacogenetics can help to identify patients likely to undergo severe toxicities when given cytotoxics showing impaired detoxification in relation with genetic polymorphism, such as canonical 5-FU. [ 32 ]

  3. Cancer pharmacogenomics - Wikipedia

    en.wikipedia.org/wiki/Cancer_Pharmacogenomics

    Cancer pharmacogenomics is the study of how variances in the genome influences an individual’s response to different cancer drug treatments. It is a subset of the broader field of pharmacogenomics , which is the area of study aimed at understanding how genetic variants influence drug efficacy and toxicity.

  4. Molecular diagnostics - Wikipedia

    en.wikipedia.org/wiki/Molecular_diagnostics

    For example, the ColoGuard test may be used to screen people over 55 years old for colorectal cancer. [57] Cancer is a longtime-scale disease with various progression steps, molecular diagnostics tools can be used for prognosis of cancer progression. For example, the OncoType Dx test by Genomic Health can estimate risk of breast cancer.

  5. Pharmacoepigenetics - Wikipedia

    en.wikipedia.org/wiki/Pharmacoepigenetics

    Some examples include procaine, hydralazine, and procainimide, but they lack specificity and potency making it hard to test them in clinical trials. DNA methyltranferase inhibitors are usually used at a low level due to their lack of specificity and toxic effects on normal cells.

  6. PharmGKB - Wikipedia

    en.wikipedia.org/wiki/PharmGKB

    Genetic testing recommended: The label states or implies that some sort of gene, protein or chromosomal testing, including genetic testing, functional protein assays, cytogenetic studies, etc., is recommended before using this drug. This recommendation may only be for a particular subset of patients.

  7. Mercaptopurine - Wikipedia

    en.wikipedia.org/wiki/Mercaptopurine

    [25] [27] The FDA-approved drug label for mercaptopurine recommends testing for TPMT activity to identify people at risk for myelotoxicity. [28] [29] Testing for TPMT activity is an example of pharmacogenetics being translated into routine clinical care. [30]